Inventor
ZHANG JACK YONGFENG
US20 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG JACK YONGFENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMPHASTAR PHARMACEUTICALS INC
16 patentsUS6793076B1Sep 21, 2004
Glass bottle protective enclosure
AMPHASTAR PHARMACEUTICALS INC69 citations93
US6399087B1Jun 4, 2002
Propofol formulation with enhanced microbial inhibition
AMPHASTAR PHARMACEUTICALS INC76 citations93
US6827479B1Dec 7, 2004
Uniform small particle homogenizer and homogenizing process
AMPHASTAR PHARMACEUTICALS INC34 citations91
US6457612B1Oct 1, 2002
Sealable and manipulable pre-filled disposable pipette
AMPHASTAR PHARMACEUTICALS INC38 citations91
US8367734B1Feb 5, 2013
Stable epinephrine suspension formulation with high inhalation delivery efficiency
AMPHASTAR PHARMACEUTICALS INC50 citations90
US7219816B1May 22, 2007
Easily sealed and opened pre-filled, disposable pipette
AMPHASTAR PHARMACEUTICALS INC19 citations82
US7468394B1Dec 23, 2008
Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation
AMPHASTAR PHARMACEUTICALS INC3 citations62
US11446360B2Sep 20, 2022
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
AMPHASTAR PHARMACEUTICALS INC0 citations58
US12383516B1Aug 12, 2025
Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent
AMPHASTAR PHARMACEUTICALS INC0 citations57
US12496272B1Dec 16, 2025
Stable epinephrine suspension formulation for inhalation with HFO propellant
AMPHASTAR PHARMACEUTICALS INC0 citations52
US10406210B2Sep 10, 2019
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
AMPHASTAR PHARMACEUTICALS INC0 citations48
US10322168B2Jun 18, 2019
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
AMPHASTAR PHARMACEUTICALS INC0 citations48
US11524987B2Dec 13, 2022
Highly purified recombinant human insulin (RHI) API and methods of producing the same
AMPHASTAR PHARMACEUTICALS INC0 citations46
US12564562B2Mar 3, 2026
Injectable epinephrine formulations demonstrating stability over time
AMPHASTAR PHARMACEUTICALS INC0 citations42
US11726049B2Aug 15, 2023
Small angle x-ray scattering methods for characterizing the iron core of iron carbohydrate colloid drug products
AMPHASTAR PHARMACEUTICALS INC0 citations38
US10258573B2Apr 16, 2019
Micronized insulin and micronized insulin analogues prepared under acidic conditions, and methods of manufacturing the same under acidic conditions
AMPHASTAR PHARMACEUTICALS INC0 citations37